Page last updated: 2024-10-19

nitrates and Cirrhosis, Liver

nitrates has been researched along with Cirrhosis, Liver in 68 studies

Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.

Research Excerpts

ExcerptRelevanceReference
"Thioacetamide (TAA) administration is widely used for induction of liver cirrhosis in rats, where reactive oxygen radicals (ROS) and nitric oxide (NO) participate in development of liver damage."7.85Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide. ( Amirtharaj, GJ; Balasubramanian, KA; Natarajan, SK; Pulimood, A; Ramachandran, A; Venkatraman, A, 2017)
"The aims of this study were to examine the plasma nitrate/nitrite (NOx; two end products of nitric oxide metabolism) and endothelin-1 (ET-1) concentrations in patients with liver cirrhosis, and to investigate whether there is a relationship between these two vasoactive parameters and the course of disease."7.73Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis. ( Canbaz, M; Curgunlu, A; Erten, N; Karan, MA; Tascioglu, C; Vural, P, 2005)
" Increased levels of endothelin 1 (ET-1) and nitrites and nitrates (NOx, the end products of NO metabolism) have been reported in hepatocellular carcinoma (HCC), but the balance has not been studied."7.71Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma. ( Kouroumalis, A; Kouroumalis, E; Notas, G; Valatas, V; Xidakis, C, 2001)
"We measured plasma nitrites/nitrates as being representative for NO release in blood of patients with chronic hepatitis C without cirrhosis (n = 20), cirrhosis of different aetiologies (n = 30) including HCV, HCC (n = 22) and in healthy controls (n = 8), by an enzyme-linked immunosorbent assay."7.70Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. ( Hayes, PC; Moussa, YI; Plevris, JN, 2000)
" However, acute and chronic administration of L-NAME did not change HE scores in cirrhotic rats."5.46Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats. ( Dehpour, AR; Gharedaghi, MH; Ghiassy, B; Javadi-Paydar, M; Norouzi-Javidan, A; Rahimi, N, 2017)
"Based on low-certainty evidence, beta-blockers, variceal band ligation, sclerotherapy, and beta-blockers plus nitrates may decrease mortality compared to no intervention in people with high-risk oesophageal varices in people with cirrhosis and no previous history of bleeding."5.12Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021)
"Thioacetamide (TAA) administration is widely used for induction of liver cirrhosis in rats, where reactive oxygen radicals (ROS) and nitric oxide (NO) participate in development of liver damage."3.85Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide. ( Amirtharaj, GJ; Balasubramanian, KA; Natarajan, SK; Pulimood, A; Ramachandran, A; Venkatraman, A, 2017)
"To investigate possible abnormalities of vasoactive compounds, nitrative stress, and antioxidant activity of paraoxonase (PONa) in human hepatopulmonary syndrome (HPS), we determined endothelin-1 (ET), nitric oxide (NOx) metabolites, PONa alongside crude plasma nitrotyrosine (NT) as surrogate marker of nitrative stress."3.83Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome. ( Ames, PR; Amitrano, L; Arcaro, A; Batuca, JR; Gentile, F; Guardascione, M, 2016)
"This study aimed to determine whether serum levels of nitric oxide metabolites (nitrates and nitrites) correlate with renal dysfunction in patients with liver cirrhosis and, moreover, to assess nitric oxide metabolite (NOx) power for predicting hepatorenal syndrome (HRS) in such patients."3.80Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis? ( Abdelkader, NA; Mahmoud, WA; Mansor, A, 2014)
"Cyclic GMP (cGMP) concentration is increased in plasma of patients with liver cirrhosis."3.73Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis. ( Del Olmo, JA; Felipo, V; Kosenko, E; Montoliu, C; Rodrigo, JM; Serra, MA, 2005)
"The aims of this study were to examine the plasma nitrate/nitrite (NOx; two end products of nitric oxide metabolism) and endothelin-1 (ET-1) concentrations in patients with liver cirrhosis, and to investigate whether there is a relationship between these two vasoactive parameters and the course of disease."3.73Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis. ( Canbaz, M; Curgunlu, A; Erten, N; Karan, MA; Tascioglu, C; Vural, P, 2005)
"We studied whether acute administration of NCX-1000, a nitric oxide (NO)-releasing derivative of ursodeoxycholic acid (UDCA), to animals with established liver cirrhosis decreases intrahepatic resistance and modulates hepatic vascular hypereactivity to norepinephrine (NE)."3.72NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver. ( Acuto, G; Antonelli, E; Baldoni, M; Brancaleone, V; Clerici, C; Del Soldato, P; Distrutti, E; Fiorucci, S; Morelli, A; Orlandi, S; Sanpaolo, L, 2003)
" Increased levels of endothelin 1 (ET-1) and nitrites and nitrates (NOx, the end products of NO metabolism) have been reported in hepatocellular carcinoma (HCC), but the balance has not been studied."3.71Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma. ( Kouroumalis, A; Kouroumalis, E; Notas, G; Valatas, V; Xidakis, C, 2001)
"We measured plasma nitrites/nitrates as being representative for NO release in blood of patients with chronic hepatitis C without cirrhosis (n = 20), cirrhosis of different aetiologies (n = 30) including HCV, HCC (n = 22) and in healthy controls (n = 8), by an enzyme-linked immunosorbent assay."3.70Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. ( Hayes, PC; Moussa, YI; Plevris, JN, 2000)
"Minimal hepatic encephalopathy (MHE) is common in cirrhosis but its pathophysiologic basis remains undefined."2.73Role of ammonia and inflammation in minimal hepatic encephalopathy. ( Jalan, R; Olde Damink, SW; Shawcross, DL; Wright, G, 2007)
"About 15% to 20% of oesophageal varices bleed in about one to three years of diagnosis."2.72Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Fritche, D; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021)
"About 15% to 20% of oesophageal varices bleed within about one to three years after diagnosis."2.72Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Milne, EJ; Pavlov, CS; Roberts, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Walshaw, D; Williams, NR, 2021)
"In conclusion, chronic administration of organic nitrates, allowing for a nitrate-free interval each day, to cirrhotic patients reduces portal pressure with a variable, dose-dependent effect on azygos blood flow."2.39Organic nitrates in portal hypertension. ( Hayes, PC; Jones, AL, 1994)
" However, acute and chronic administration of L-NAME did not change HE scores in cirrhotic rats."1.46Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats. ( Dehpour, AR; Gharedaghi, MH; Ghiassy, B; Javadi-Paydar, M; Norouzi-Javidan, A; Rahimi, N, 2017)
"Oxidative stress, liver fibrosis and angiogenesis may be implicated in n-TiO2-induced liver toxicity."1.42Potential antifibrotic and angiostatic impact of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury. ( Abdelazim, SA; Ali, SA; Darwish, HA; Kadry, MO; Rizk, MZ, 2015)
"Portal hypertension was present at 12 weeks (11 +/- 0."1.33A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. ( Fevery, J; Laleman, W; Libbrecht, L; Nevens, F; Roskams, T; Servaes, R; Vander Elst, I; Zeegers, M, 2006)
"Gallstones were common in patients with liver cirrhosis and the prevalence increased with the progression of liver diseases."1.31Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. ( Chang, FY; Chu, CJ; Hwang, SJ; Lee, FY; Lee, SD; Li, CP; Lin, HC; Lu, RH, 2000)
"Patients with liver cirrhosis have a nocturnal worsening of hemodynamic parameters that has been associated with an increased risk of variceal bleeding at nighttime."1.31Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients. ( Catalan, R; Cereto, F; Esteban, R; Genesca, J; Gonzalez, A; Guardia, J; Marti, R; Martinez, M; Segura, R; Torregrosa, M, 2000)
"Liver cirrhosis is associated with enlarged right cardiac chambers."1.31Modification of cardiac function in cirrhotic patients with and without ascites. ( De Castro, S; Fiore, P; Funaro, S; Lionetti, R; Masini, A; Merli, M; Pulcinelli, G; Riggio, O; Valeriano, V, 2000)
"The prevalence of large esophageal varices was 20%."1.30Predictors of large esophageal varices in patients with cirrhosis. ( Boyer, TD; Carey, M; Chalasani, N; Imperiale, TF; Ismail, A; Kwo, PY; Madichetty, H; Sood, G; Wilcox, CM, 1999)

Research

Studies (68)

TimeframeStudies, this research(%)All Research%
pre-19902 (2.94)18.7374
1990's20 (29.41)18.2507
2000's28 (41.18)29.6817
2010's15 (22.06)24.3611
2020's3 (4.41)2.80

Authors

AuthorsStudies
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X5
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J4
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X5
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H5
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y7
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L4
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y4
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z3
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C3
Liu, W1
Chen, W2
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P2
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q3
Liu, X4
Huang, Y3
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y2
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S2
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Plaz Torres, MC2
Best, LM3
Freeman, SC3
Roberts, D3
Cooper, NJ3
Sutton, AJ3
Roccarina, D2
Benmassaoud, A2
Iogna Prat, L2
Williams, NR3
Csenar, M3
Fritche, D1
Begum, T3
Arunan, S3
Tapp, M3
Milne, EJ3
Pavlov, CS3
Davidson, BR4
Tsochatzis, E3
Gurusamy, KS3
Walshaw, D1
Mahmoud, WA1
Abdelkader, NA1
Mansor, A1
Abdelazim, SA1
Darwish, HA1
Ali, SA1
Rizk, MZ1
Kadry, MO1
Ames, PR1
Guardascione, M1
Batuca, JR1
Arcaro, A1
Gentile, F1
Amitrano, L1
Bottari, NB1
Mendes, RE1
Lucca, NJ1
Schwertz, CI1
Henker, LC1
Olsson, DC1
Piva, MM1
Sangoi, M1
Campos, LP1
Moresco, RN1
Jaques, JA1
Da silva, AS1
Mahmoodi, S1
Rahmatollahi, M1
Shahsavari, F1
Shafaroodi, H1
Grayesh-Nejad, S1
Dehpour, AR2
Aebischer, B1
Elsig, S1
Taeymans, J1
Pomp, S1
Kuhness, D1
Barcaro, G1
Sementa, L1
Mankad, V1
Fortunelli, A1
Sterrer, M1
Netzer, FP1
Surnev, S1
Schmieder, AH1
Caruthers, SD1
Keupp, J1
Wickline, SA1
Lanza, GM1
Lowe, J1
Wodarcyk, AJ1
Floyd, KT1
Rastogi, N1
Schultz, EJ1
Swager, SA1
Chadwick, JA1
Tran, T1
Raman, SV1
Janssen, PM1
Rafael-Fortney, JA1
Alcalay, RN1
Levy, OA1
Wolf, P1
Oliva, P1
Zhang, XK1
Waters, CH1
Fahn, S1
Kang, U1
Liong, C1
Ford, B1
Mazzoni, P1
Kuo, S1
Johnson, A1
Xiong, L1
Rouleau, GA1
Chung, W1
Marder, KS1
Gan-Or, Z1
Kamei, K1
Terao, T1
Katayama, Y1
Hatano, K1
Kodama, K1
Shirahama, M1
Sakai, A1
Hirakawa, H1
Mizokami, Y1
Shiotsuki, I1
Ishii, N1
Inoue, Y1
Akboga, MK1
Yayla, C1
Balci, KG1
Ozeke, O1
Maden, O1
Kisacik, H1
Temizhan, A1
Aydogdu, S1
Ying, SH1
Feng, MG1
Zhang, XG1
Hao, YY1
Liang, GD1
Ma, YH1
Yang, GS1
Hu, JH1
Pfeifer, L1
Goertz, RS1
Neurath, MF1
Strobel, D1
Wildner, D1
Lin, JT1
Yang, XN1
Zhong, WZ1
Liao, RQ1
Nie, Q1
Weng, SX1
Fang, XJ1
Zheng, JY1
Wu, YL1
Řezanka, T1
Kaineder, K1
Mezricky, D1
Řezanka, M1
Bišová, K1
Zachleder, V1
Vítová, M1
Rinker, JA1
Marshall, SA1
Mazzone, CM1
Lowery-Gionta, EG1
Gulati, V1
Pleil, KE1
Kash, TL1
Navarro, M1
Thiele, TE1
Jin, Z1
Li, B1
Xu, P1
Fokdal, L1
Sturdza, A1
Mazeron, R1
Haie-Meder, C1
Tan, LT1
Gillham, C1
Šegedin, B1
Jürgenliemk-Schultz, I1
Kirisits, C1
Hoskin, P1
Pötter, R1
Lindegaard, JC1
Tanderup, K1
Levin, DE1
Schmitz, AJ1
Hines, SM1
Hines, KJ1
Tucker, MJ1
Brewer, SH1
Fenlon, EE1
Álvarez-Pérez, S1
Blanco, JL1
Peláez, T1
Martínez-Nevado, E1
García, ME1
Puckerin, AA1
Chang, DD1
Subramanyam, P1
Colecraft, HM1
Dogan, H1
Coteli, E1
Karatas, F1
Ceylan, O1
Sahin, MD1
Akdamar, G1
Kryczyk, A1
Żmudzki, P1
Hubicka, U1
Giovannelli, D1
Chung, M1
Staley, J1
Starovoytov, V1
Le Bris, N1
Vetriani, C1
Wu, L1
Liang, Y1
Tan, H1
Wang, M1
Liu, L1
Liu, B1
Liu, GH1
Zhu, YJ1
Wang, JP1
Che, JM1
Chen, QQ1
Maucksch, U1
Runge, R1
Wunderlich, G1
Freudenberg, R1
Naumann, A1
Kotzerke, J1
Amirtharaj, GJ1
Natarajan, SK1
Pulimood, A1
Balasubramanian, KA1
Venkatraman, A1
Ramachandran, A1
Ghiassy, B1
Rahimi, N1
Javadi-Paydar, M1
Gharedaghi, MH1
Norouzi-Javidan, A1
Kinjo, N1
Kawanaka, H1
Akahoshi, T1
Yamaguchi, S1
Yoshida, D1
Anegawa, G1
Konishi, K1
Tomikawa, M1
Tanoue, K1
Tarnawski, A1
Hashizume, M1
Maehara, Y1
Berzigotti, A1
Bellot, P1
De Gottardi, A1
Garcia-Pagan, JC1
Gagnon, C1
Spénard, J1
Bosch, J1
Görg, B1
Qvartskhava, N1
Bidmon, HJ1
Palomero-Gallagher, N1
Kircheis, G1
Zilles, K1
Häussinger, D1
Kajita, M1
Murata, T1
Horiguchi, K1
Iizuka, M1
Hori, M1
Ozaki, H1
Ergün, Y2
Kurutaş, EB1
Ozdil, B1
Güneşaçar, R1
Afzelius, P1
Bazeghi, N1
Bie, P1
Bendtsen, F1
Vestbo, J1
Møller, S1
Naffaa, M1
Abu-Saleh, N1
Awad, H1
Khamaysi, I1
Karram, T1
Azzam, ZS1
Abassi, Z1
Bishara, B1
Arkenau, HT1
Stichtenoth, DO1
Frölich, JC1
Manns, MP1
Böker, KH1
McNaughton, L1
Puttagunta, L1
Martinez-Cuesta, MA1
Kneteman, N1
Mayers, I1
Moqbel, R1
Hamid, Q1
Radomski, MW1
Iga, A1
Nomura, M1
Sawada, Y1
Ito, S1
Nakaya, Y1
Fiorucci, S3
Antonelli, E3
Morelli, A3
Yang, YY3
Lin, HC4
Lee, WC2
Huang, YT3
Hou, MC3
Lee, FY4
Chang, FY4
Lee, SD4
Tahan, V1
Avsar, E1
Karaca, C1
Uslu, E1
Eren, F1
Aydin, S1
Uzun, H1
Hamzaoglu, HO1
Besisik, F1
Kalayci, C1
Okten, A1
Tozun, N1
Kotzampassi, K1
Metaxas, G1
Paramythiotis, D1
Pidonia, I1
Rekka, H1
Karamouzis, M1
Eleftheriadis, E1
Brancaleone, V1
Sanpaolo, L1
Orlandi, S1
Distrutti, E1
Acuto, G1
Clerici, C1
Baldoni, M1
Del Soldato, P2
Loureiro-Silva, MR1
Cadelina, GW1
Iwakiri, Y1
Groszmann, RJ2
Coll, S1
Vila, MC1
Molina, L1
Gimenez, MD1
Guarner, C2
Solà, R1
Montoliu, C1
Kosenko, E1
Del Olmo, JA1
Serra, MA1
Rodrigo, JM1
Felipo, V1
Curgunlu, A1
Vural, P1
Canbaz, M1
Erten, N1
Karan, MA1
Tascioglu, C1
Rockey, DC1
Laleman, W1
Vander Elst, I1
Zeegers, M1
Servaes, R1
Libbrecht, L1
Roskams, T1
Fevery, J1
Nevens, F1
Engin, A1
Dinçer, S1
Ercan, SZ1
Memiş, L1
Bukan, N2
Bozkurt, S1
Shawcross, DL1
Wright, G1
Olde Damink, SW1
Jalan, R1
Soriano, G1
Tomas, A1
Bulbena, O1
Novella, MT1
Balanzo, J1
Vilardell, F1
Mourelle, M1
Moncada, S1
Jones, AL1
Hayes, PC2
El-Newihi, HM1
Kanji, VK1
Mihas, AA1
Yokoyama, M3
Shijo, H3
Ota, K3
Kubara, K3
Kokawa, H2
Kim, T3
Akiyoshi, N3
Okumura, M3
Inoue, K3
Hori, N1
Okanoue, T1
Mori, T1
Kashima, K1
Nishimura, M1
Nanbu, A1
Yoshimura, M1
Takahashi, H1
Campillo, B2
Bories, PN3
Benvenuti, C1
Dupeyron, C1
Azaou, L1
Scherman, E1
Moriyama, A1
Masumoto, A1
Nanri, H1
Tabaru, A1
Unoki, H1
Imoto, I1
Ikeda, M1
Otsuki, M1
Rolla, G1
Brussino, L1
Colagrande, P1
Dutto, L1
Polizzi, S1
Scappaticci, E1
Bergerone, S1
Morello, M1
Marzano, A1
Martinasso, G1
Salizzoni, M1
Bucca, C1
Kakumitsu, S1
Cuzzocrea, S1
Zingarelli, B1
Villari, D1
Caputi, AP1
Longo, G1
Angeli, P1
Volpin, R1
Piovan, D1
Bortoluzzi, A1
Craighero, R1
Bottaro, S1
Finucci, GF1
Casiglia, E1
Sticca, A1
De Toni, R1
Pavan, L1
Gatta, A1
Genesca, J2
Gonzalez, A2
Segura, R2
Catalan, R2
Marti, R2
Varela, E1
Cadelina, G1
Martinez, M2
Lopez-Talavera, JC1
Esteban, R2
Guardia, J2
Sarela, AI1
Mihaimeed, FM1
Batten, JJ1
Mathie, RT1
Heller, J2
Kristeleit, H1
Brensing, KA1
Woitas, RP1
Spengler, U1
Sauerbruch, T1
Barak, N1
Zemel, R1
Ben-Ari, Z1
Braun, M1
Tur-Kaspa, R1
Acosta, F1
Serrano, E1
Diaz, J1
Carbonell, L1
Sansano, T1
Beltran, R1
Roques, V1
Contreras, RF1
Robles, R1
Bueno, FS1
Ramirez, P1
Parrilla, P1
Chalasani, N1
Imperiale, TF1
Ismail, A1
Sood, G1
Carey, M1
Wilcox, CM1
Madichetty, H1
Kwo, PY1
Boyer, TD1
Moussa, YI1
Plevris, JN1
Hon, WM1
Lee, JC1
Lee, KH1
Li, CP1
Hwang, SJ1
Lu, RH1
Chu, CJ1
Torregrosa, M1
Cereto, F1
Sogni, P1
Barrière, E1
Tazi, KA1
Chauvelot-Moachon, L1
Guimont, MC1
Poirel, O1
Moreau, R1
Lebrec, D1
Valeriano, V1
Funaro, S1
Lionetti, R1
Riggio, O1
Pulcinelli, G1
Fiore, P1
Masini, A1
De Castro, S1
Merli, M1
Notas, G1
Xidakis, C1
Valatas, V1
Kouroumalis, A1
Kouroumalis, E1
Coşkun, U1
Ozenirler, S1
Sancak, B1
Lee, TY2
Morelli, O1
Mencarelli, A1
Casini, A1
Mello, T1
Palazzetti, B1
Tallet, D1
Liu, RS1
Vorob'ev, LP1
Maev, IV1
Blei, AT1
Schierge, M1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations[NCT02799160]22 participants (Actual)Observational2016-10-01Active, not recruiting
Evaluation of the Therapeutic Effect of Rifaximin on Covert Hepatic Encephalopathy With Underlying Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility in Liver Cirrhosis Patients[NCT04244877]Phase 30 participants (Actual)Interventional2021-09-15Withdrawn (stopped due to Study was unable to recruit participants..)
Diagnostic Accuracy of Spleen and Liver Stiffness Measurement by EUS-elastography, to Predict Portal Hypertension in Patients With Cirrhosis.[NCT03155282]61 participants (Actual)Observational2017-03-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

9 reviews available for nitrates and Cirrhosis, Liver

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
    The Cochrane database of systematic reviews, 2021, 03-30, Volume: 3

    Topics: Adrenergic beta-2 Receptor Antagonists; Adult; Bias; Esophageal and Gastric Varices; Gastrointestina

2021
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
    The Cochrane database of systematic reviews, 2021, 04-06, Volume: 4

    Topics: Adrenergic beta-Antagonists; Bias; Combined Modality Therapy; Drug Therapy, Combination; Esophageal

2021
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
    The Cochrane database of systematic reviews, 2021, 04-10, Volume: 4

    Topics: Adult; Bayes Theorem; Bias; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointesti

2021
    Hand therapy, 2016, Volume: 21, Issue:1

    Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; A

2016
Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
    Current gastroenterology reports, 2006, Volume: 8, Issue:1

    Topics: Adrenergic beta-Antagonists; Algorithms; Antihypertensive Agents; Cardiovascular Agents; Esophageal

2006
Organic nitrates in portal hypertension.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:1

    Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans

1994
[New trends in the treatment of hemodynamic disorders in liver cirrhosis].
    Klinicheskaia meditsina, 1991, Volume: 69, Issue:9

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Drug Evaluation; Hem

1991
Pharmacokinetic-hemodynamic interactions in cirrhosis.
    Seminars in liver disease, 1986, Volume: 6, Issue:4

    Topics: Hemodynamics; Humans; Kinetics; Liver Circulation; Liver Cirrhosis; Nitrates; Propranolol; Vasopress

1986

Trials

3 trials available for nitrates and Cirrhosis, Liver

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
NCX-1000, a nitric oxide-releasing derivative of UDCA, does not decrease portal pressure in patients with cirrhosis: results of a randomized, double-blind, dose-escalating study.
    The American journal of gastroenterology, 2010, Volume: 105, Issue:5

    Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administrati

2010
Role of ammonia and inflammation in minimal hepatic encephalopathy.
    Metabolic brain disease, 2007, Volume: 22, Issue:1

    Topics: Adult; Aged; Amino Acids; Ammonia; Biomarkers; C-Reactive Protein; Female; Hepatic Encephalopathy; H

2007

Other Studies

57 other studies available for nitrates and Cirrhosis, Liver

ArticleYear
Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014, Volume: 33, Issue:3

    Topics: Adult; Biomarkers; Case-Control Studies; Female; Forecasting; Hepatitis C, Chronic; Hepatorenal Synd

2014
Potential antifibrotic and angiostatic impact of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:6

    Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Antioxidants; Aspartate Aminotransferases; C

2015
Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:1

    Topics: Aged; Aryldialkylphosphatase; Biomarkers; Cross-Sectional Studies; Endothelin-1; Female; Hepatopulmo

2016
Oxidative stress associated with pathological lesions in the liver of rats experimentally infected by Fasciola hepatica.
    Experimental parasitology, 2015, Volume: 159

    Topics: Advanced Oxidation Protein Products; Animals; Antioxidants; Fascioliasis; Lipid Peroxidation; Liver;

2015
Increased Salivary Nitrite and Nitrate Excretion in Rats with Cirrhosis.
    Acta medica Iranica, 2015, Volume: 53, Issue:11

    Topics: Animals; Liver Cirrhosis; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Rats; Rats,

2015
Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide.
    Cardiovascular toxicology, 2017, Volume: 17, Issue:2

    Topics: Animals; Chemical and Drug Induced Liver Injury; Female; Heart Diseases; Lipid Peroxidation; Liver;

2017
Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1

    Topics: Animals; Drug Interactions; Hepatic Encephalopathy; Lipopolysaccharides; Liver; Liver Cirrhosis; Mal

2017
Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications.
    American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 295, Issue:5

    Topics: Alanine; Animals; Enzyme Inhibitors; Ethanol; Extracellular Signal-Regulated MAP Kinases; Gastric Mu

2008
Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:1

    Topics: Adult; Aged; Amino Acid Transport System X-AG; Biomarkers; Cerebral Cortex; Excitatory Amino Acid Tr

2010
iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats.
    American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:3

    Topics: Animals; Calcium; Cyclic GMP; Hypertension, Portal; Lipopolysaccharides; Liver Cirrhosis; Macrophage

2011
Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis.
    Clinics and research in hepatology and gastroenterology, 2011, Volume: 35, Issue:4

    Topics: Adult; Case-Control Studies; Humans; Liver Cirrhosis; Middle Aged; Nitrates; Nitrites; Oxidative Str

2011
Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:9

    Topics: Adult; Aged; Biomarkers; Breath Tests; Case-Control Studies; Denmark; Female; Heart Rate; Hemodynami

2011
Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide.
    Surgical endoscopy, 2013, Volume: 27, Issue:7

    Topics: Acute Disease; Animals; Cyclic GMP; Glomerular Filtration Rate; Jaundice, Obstructive; Liver Cirrhos

2013
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
    Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:11

    Topics: Ascites; Data Interpretation, Statistical; Esophageal and Gastric Varices; Hemodynamics; Hepatitis,

2002
Distribution of nitric oxide synthase in normal and cirrhotic human liver.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-24, Volume: 99, Issue:26

    Topics: Blotting, Western; Humans; Immunohistochemistry; In Situ Hybridization; Liver; Liver Cirrhosis; Nitr

2002
Autonomic nervous dysfunction in patients with liver cirrhosis using 123I-metaiodobenzylguanidine myocardial scintigraphy and spectrum analysis of heart-rate variability.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Bilirubin; Biomarkers; Circadian Rhy

2003
Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35 Suppl 2

    Topics: Adipocytes; Animals; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Nitrates; Nitric Oxide; U

2003
Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:10

    Topics: Anemia; Ascites; Blood Pressure; Cardiac Output; Erythropoietin; Hepatic Veins; Humans; Hypertension

2003
Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
    World journal of gastroenterology, 2003, Volume: 9, Issue:10

    Topics: Adrenomedullin; Adult; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nit

2003
The influence of continuous seven-day elevated intra-abdominal pressure in the renal perfusion in cirrhotic rats.
    The Journal of surgical research, 2003, Volume: 115, Issue:1

    Topics: Abdomen; Aldosterone; Animals; Blood Pressure; Carbon Tetrachloride; Catheterization; Femoral Artery

2003
NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.
    Journal of hepatology, 2003, Volume: 39, Issue:6

    Topics: Animals; Bile; Blood Pressure; Drug Interactions; Hypertension, Portal; In Vitro Techniques; Liver C

2003
A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats.
    Journal of hepatology, 2003, Volume: 39, Issue:6

    Topics: Animals; Drug Interactions; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Mesenter

2003
Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:3

    Topics: Abdomen; Aldosterone; Ascites; Ascitic Fluid; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Ni

2004
Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:4

    Topics: Adult; Aged; Ascites; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Guanylate Cyclase; Hum

2005
Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis.
    Journal of clinical laboratory analysis, 2005, Volume: 19, Issue:5

    Topics: Adult; Disease Progression; Endothelin-1; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrat

2005
A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
    European journal of clinical investigation, 2006, Volume: 36, Issue:4

    Topics: Administration, Oral; Analysis of Variance; Animals; Carcinogens; Hemodynamics; Hypertension, Portal

2006
Regulation of fibrogenesis during the early phase of common bile duct obstruction.
    ANZ journal of surgery, 2006, Volume: 76, Issue:7

    Topics: Animals; Cell Proliferation; Cholestasis; Collagen; Common Bile Duct Diseases; Dinoprostone; Disease

2006
Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
    Hepatology (Baltimore, Md.), 1993, Volume: 18, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colistin; Endotoxins; Humans; Liver Cirrhosis; Middl

1993
Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:3

    Topics: Adult; Aged; Esophageal and Gastric Varices; Gastric Mucosa; Humans; Hypertension, Portal; Liver Cir

1996
Systemic hemodynamics and serum nitrate levels in patients undergoing endoscopic variceal ligation.
    Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:1

    Topics: Aldosterone; Analysis of Variance; Bile Acids and Salts; Blood Pressure; Cardiac Output; Echocardiog

1996
Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis.
    Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:1

    Topics: Adult; Aged; Blood Platelets; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrates; Nitric O

1996
Nitrate kinetics in patients with compensated cirrhosis: correlation with hemodynamics.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:10

    Topics: Blood Flow Velocity; Case-Control Studies; Female; Humans; Liver Circulation; Liver Cirrhosis; Male;

1996
Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation.
    Journal of hepatology, 1996, Volume: 25, Issue:5

    Topics: Analysis of Variance; Cardiac Output, High; Case-Control Studies; Echocardiography, Doppler; Endotox

1996
Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
    Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacterial Infections; C-Reactive Protein; Female; Hum

1997
High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Analysis of Variance; Carcinoma, Hepatocellular; Case-Control Studies; Cytotoxicity, Immunologic; Fe

1997
Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:4

    Topics: Adult; Echocardiography; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrates; Nitric Oxide;

1997
Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Hepatology (Baltimore, Md.), 1998, Volume: 27, Issue:2

    Topics: Aged; Arginine; Bile Acids and Salts; Blood Circulation; Female; Humans; Liver Circulation; Liver Ci

1998
Evidence for in vivo peroxynitrite production in human chronic hepatitis.
    Life sciences, 1998, Volume: 63, Issue:2

    Topics: Adult; Antibodies; Antibody Specificity; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans;

1998
Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Hepatology (Baltimore, Md.), 1998, Volume: 28, Issue:4

    Topics: Administration, Oral; Adrenergic alpha-Agonists; Ascites; Blood Pressure; Cardiac Output; Female; Gl

1998
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:1

    Topics: Aged; Aldosterone; Ascites; Blood Pressure; Endotoxins; Female; Hepatic Encephalopathy; Humans; Inte

1999
Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.
    Gut, 1999, Volume: 44, Issue:5

    Topics: Adult; Aged; Female; Humans; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nitra

1999
Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state.
    Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:3

    Topics: Case-Control Studies; Fasting; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Nitrates;

1999
Nitric oxide metabolites in decompensated liver cirrhosis.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:7

    Topics: Adult; Aged; Angina Pectoris; Female; Hemoglobins; Humans; Kidney Failure, Chronic; Liver Cirrhosis;

1999
Hemodynamic consequences of oxidative stress following reperfusion during liver transplantation.
    Transplantation proceedings, 1999, Volume: 31, Issue:6

    Topics: Analysis of Variance; Blood Pressure; Hemodynamics; Humans; Liver Cirrhosis; Liver Transplantation;

1999
Predictors of large esophageal varices in patients with cirrhosis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:11

    Topics: Adrenergic beta-Antagonists; Cohort Studies; Confidence Intervals; Cost-Benefit Analysis; Costs and

1999
Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
    European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:2

    Topics: Adult; Carcinoma, Hepatocellular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; H

2000
Effect of hemodialysis on plasma nitric oxide levels.
    Artificial organs, 2000, Volume: 24, Issue:5

    Topics: Colorimetry; Cyclic GMP; Female; Follow-Up Studies; Humans; Inflammation Mediators; Kidney Failure,

2000
Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:6

    Topics: Aged; Cholelithiasis; Disease Progression; Eating; Estradiol; Female; Gallbladder; Humans; Liver Cir

2000
Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:6

    Topics: Aged; Blood Pressure; Circadian Rhythm; Cytokines; Female; Heart Rate; Hemodynamics; Humans; Liver C

2000
Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis.
    Journal of hepatology, 2000, Volume: 33, Issue:3

    Topics: Animals; Lipopolysaccharides; Liver; Liver Cirrhosis; Macrophages, Peritoneal; Male; Nitrates; Nitri

2000
Modification of cardiac function in cirrhotic patients with and without ascites.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:11

    Topics: Ascites; Cardiomyopathies; Case-Control Studies; Echocardiography; Echocardiography, Doppler, Color;

2000
Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma.
    Journal of viral hepatitis, 2001, Volume: 8, Issue:1

    Topics: Carcinoma, Hepatocellular; Endothelin-1; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepati

2001
Serum and ascitic fluid nitrate levels in patients with cirrhosis.
    Clinica chimica acta; international journal of clinical chemistry, 2001, Volume: 306, Issue:1-2

    Topics: Ascites; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrates

2001
Adaptive vasodilatory response after octreotide treatment.
    American journal of physiology. Gastrointestinal and liver physiology, 2001, Volume: 281, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blotting, Western; Cyclooxygenase Inhibitors; Dose-Res

2001
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Jul-17, Volume: 98, Issue:15

    Topics: Animals; Carbon Tetrachloride; Collagen; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Nitrate

2001
Effect of 1-week losartan administration on bile duct-ligated cirrhotic rats with portal hypertension.
    Journal of hepatology, 2002, Volume: 36, Issue:5

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blotting, Western; Common Bile Duct; Enzyme Inhibi

2002
[Determination of plasmin activity for clinical purposes].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1966, Apr-15, Volume: 21, Issue:8

    Topics: Acetone; Caseins; Cholangitis; Fibrinolysin; Hepatitis A; Humans; Indicators and Reagents; Liver Cir

1966